Founded in 1990, the company was originally affiliated to Nanjing General Hospital of Nanjing Military Region, and was transferred to the local government in 1998, and was affiliated to Nanjing Pharmaceutical Industry Group Co., Ltd. The original site of the company is located atNo. 1 Shuanglong Street, Yuhuatai District, Nanjing. It passed GMP certification for the first time in May 2003 and GMP re-certification in March 2008.
In 2009, in order to support the national Beijing-Shanghai high-speed railway construction, Nanjing Pharmaceutical Industry Group took the opportunity of the relocation and transformation of Zhongshan Pharmaceutical Company and invested 65.438+0.2 billion yuan to build a modern production base of traditional Chinese medicine in Hengfa Road, Nanjing Economic and Technological Development Zone.
The company's new factory was completed in June, 20 10, and passed the on-site acceptance of drug GMP certification in early February. On June, 20 1 1, the company obtained the drug GMP certificate and put it into production smoothly. The new factory covers an area of 72 mu, and the first-phase construction area is 20,000 square meters. The extraction and production capacity of Chinese herbal medicines reaches 1 0.5 million tons/year, the capsule production capacity reaches1100 million tablets/year, the tablet production capacity reaches 300 million tablets/year, and the granule production capacity reaches 700 million bags/year.
quality assurance
The company has advanced production technology and equipment, and newly introduced Bosch automatic capsule machine, jet mill, microwave vacuum dryer, CO2 supercritical extraction device, hopper mixer, small box automatic packaging line, high performance liquid chromatograph, gas chromatograph, infrared spectrometer, atomic absorption spectrometer and other advanced equipment and inspection instruments; Have a high-quality workforce and strong technical force, with professional and technical personnel accounting for more than 46%; It has a perfect quality assurance system, implements the quality authorization system according to the requirements of the new GMP, and organizes production in strict accordance with GMP to ensure the production of high-quality products.
technical innovation
The company adheres to the innovative strategies of "combining technological innovation with digestion and absorption", "combining technological innovation with secondary development" and "combining technological innovation with intellectual property rights", and pays attention to the application of modern advanced technologies such as supercritical fluid extraction technology, ultrafine grinding technology and β -cyclodextrin inclusion technology to enhance the technical connotation of traditional Chinese medicine. The pilot workshop passed GMP certification and acceptance, and became an incubator for the company to develop new products for industrialization.
The company has 1 national protected varieties of traditional Chinese medicine, 8 new drug certificates, 5 varieties under research, 2 high-tech products in Nanjing, 2 independent innovative products and 9 patents, including 15 invention patents and 4 design patents, and has successively undertaken the National 863 Project, the National New Drug Fund Project, the National Torch Program Project and the National Torch Program Project.
"Mochou" trademark won the title of famous trademark in Nanjing, and Xu Anqi Tongbi capsule and its preparation technology patent won the top ten outstanding patents in Nanjing and the first prize of scientific and technological progress in Yuhua District. At the same time, the company attaches great importance to the combination of Industry-University-Research, and has successively become the master training point of Yanbian University and the internship base of Nanjing Normal University, with 9 graduate students and more than 20 undergraduates.
production line
The company has five series of main varieties, among which five varieties, such as Huoxue Zhitong Capsule, Ciprofloxacin Hydrochloride Capsule, Qijudihuang Capsule, Qijudihuang Tablet and Leonurus Granule, have been listed in the national list of essential drugs.
1, a medicine for treating traumatic injury, soft tissue injury, muscle pain, rheumatism and rheumatoid diseases, which mainly consists of Huoxue Zhitong capsule, Xu Anqi Tongbi capsule, compound chlorzoxazone tablet and tripterygium wilfordii total terpene tablet;
2. Zhi Zhu Granule, Baobaole and Shu Ren Jianwei Granule are mainly used to treat gastric dyspepsia, atrophic gastritis with precancerous lesions of gastric cancer; Gastrointestinal drugs mainly treat enteritis, mainly Xinqingning;
3. The main drugs used in obstetrics and gynecology are Ruquan Granule, Leonurus japonicus Granule and Qinglin Granule;
4. The drugs for enhancing immunity are mainly composed of Liuwei Dihuang concentrated capsules and Yishenling granules;
5. Xiaochaihu Granules, Fuyang Granules, Xiaoer Ganmaoshu Granules and Baiqian Biyan Tablets are mainly used to treat common diseases and frequently-occurring diseases.
marketing management
The company has established a nationwide sales network, set up offices in more than 20 provinces and cities such as Beijing, Shanghai and Jiangsu, and maintained good business cooperation with many domestic and foreign commercial customers and end customers. More than 20 kinds of Chinese and western medicines, such as orthopedics, gastroenterology and gynecology, sell well all over the country.
In the process of business development for many years, the company has summed up unique management experience and marketing model in combination with the characteristics and actual situation of pharmaceutical market development. "Reputation first, quality first, market first, service first" is our company's consistent business purpose. With the management principle of "ensuring the best interests of customers and striving for the best interests of customers", the sales network has spread all over the country, and the sales volume has doubled year after year, fully achieving a win-win situation with many distribution partners.
Under the new situation, the company will, as always, adhere to the business philosophy of "innovation, humanism, honesty and win" and the business philosophy of "caring for health and escorting life", take the market as the guide, create high-quality products, fully rely on high-quality employees, unite and work hard, strive for first-class pharmaceutical enterprises, and serve the society and patients with high-quality drugs.
Legal Representative: Cheng Jun..
Date of establishment: 1992- 12-28
Registered capital: 97 14.3 1 ten thousand yuan.
Location: Jiangsu Province
Unified social credit code: 913201921349315802.
Operating conditions: In operation.
Industry: manufacturing industry
Company type: limited liability company
English name: Nanjing Zhongshan Pharmaceutical Co., Ltd.
Number of employees: 100-499.
Enterprise address: No.21Hengfa Road, Nanjing Economic and Technological Development Zone
Scope of business: production and sales of tablets, capsules and granules; Traditional Chinese medicine extraction. Development, transfer, consultation and service of medical technology; R&D, production and sales of health food, disinfection products, cosmetics and handicrafts. (Projects subject to approval according to law can only be operated after approval by relevant departments)